Bookmark and Share
Phenformin (CID 8249) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(3)
 
 
Inactive(194)
 
 
Inconclusive(13)
 
 
Unspecified(79)
 
 
Top Targets:
p450(14)
 
 
 
 
MFS(7)
 
 
HSD10-like SD..(4)
 
 
KAZAL SLC21(3)
 
 
Firefly Luc l..(3)
 
 
BioAssay Types:
Literature(141)
 
 
 
 
 
Confirmatory(115)
 
 
 
Screening(19)
 
 
BioActivity Types:
Potency(89)
 
 
 
IC50(9)
 
 
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 217    Data Row: 289   Total Pages: 15   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103426218]
IC50 27Inhibition of MAMC O-dealkylation mediated by human Cytochrome P450 2D6 expressed in human lymphoblastoid cell line [AID54570, Type: Literature]Cytochrome P450 2D6 [gi:84028191]
View
2
[SID103426218]
IC50 45.4Inhibition of MAMC O-dealkylation mediated by rat Cytochrome P450 2D2 expressed in Saccharomyces cerevisiae [AID54564, Type: Literature]Cytochrome P450 2D26 [gi:117242]
View
3
[SID48416408]
DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database [AID1195, Type: other]
View
4
[SID103426218]
IC50 10TP_TRANSPORTER: inhibition of Cimetidine uptake (Cimetidine: 1 uM) in Xenopus laevis oocytes [AID680364, Type: Literature]Solute carrier family 22 member 1 [gi:313104181]
View
5
[SID103426218]
Km 15.6TP_TRANSPORTER: uptake in OCT1-expressing CHO cells [AID679316, Type: Literature]Solute carrier family 22 member 1 [gi:81872095]
View
6
[SID103426218]
IC50 65TP_TRANSPORTER: inhibition of Cimetidine uptake (Cimetidine: 1 uM) in Xenopus laevis oocytes [AID680369, Type: Literature]Solute carrier family 22 member 2 [gi:313104182]
View
7
[SID103426218]
IC50 180In vitro inhibition of glucose oxidation by the compound in isolated rat fat cells [AID179736, Type: Literature]
View
8
[SID103426218]
IC50 833Inhibition of MAMC O-dealkylation mediated by rat Cytochrome P450 2D4 expressed in Saccharomyces cerevisiae [AID54566, Type: Literature]Cytochrome P450 2D4 [gi:117244]
View
9
[SID103426218]
IC50 1927Inhibition of MAMC O-dealkylation mediated by rat Cytochrome P450 2D3 expressed in Saccharomyces cerevisiae [AID54565, Type: Literature]Cytochrome P450 2D3 [gi:3915646]
View
10
[SID11112448]
Cytochrome panel assay with activity outcomes [AID1851, Type: other]
View
11
[SID103426218]
IC50 Antimicrobial activity against Plasmodium falciparum [AID496819, Type: Literature]
View
12
[SID103426218]
Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans [AID588211, Type: Literature]
View
13
[SID103426218]
Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents [AID588212, Type: Literature]
View
14
[SID103426218]
Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents [AID588213, Type: Literature]
View
15
[SID103426218]
Hypoglycemic activity was given as differences between the mean changes in blood glucose concentration in control group and the treated group after a dose of 25 mg/kg, ip [AID75532, Type: Literature]
View
16
[SID103426218]
Evaluated in normal, fasted guinea pig for the percentage reduction in blood glucose level after 5 hr as compared to pretreatment blood glucose values at a dose of 25 mg of free base / kg body weight administered orally [AID77195, Type: Literature]
View
17
[SID103426218]
Percent reduction in blood glucose after perorally administration of compound at 25 mg/kg in in normal fasted guinea pig [AID77203, Type: Literature]
View
18
[SID103426218]
Evaluated in normal, fasted monkey for the percentage reduction in blood glucose level after 5 hr as compared to pretreatment blood glucose values at a dose of 10 mg of free base / kg body weight administered orally [AID126663, Type: Literature]
View
19
[SID103426218]
Lethal dose after intraperitoneal administration in mouse [AID134583, Type: Literature]
View
20
[SID103426218]
Lethal dose after peroral administration in mouse [AID134584, Type: Literature]
View